dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

Louisiana getting $14 million Center for Molecular Imaging and Therapy Increasing research opportunities, collaboration and radiopharmaceuticals

DOE transfers land to Coquí Pharma for isotope production facility Will be used primarily to produce Mo-99

PET uncovers abnormal tau deposits associated with CTE in live subjects May enable diagnosis of CTE in living people one day

Amyloid PET scans help with Alzheimer's clinical management New insights from the 11,000 patient IDEAS study

United Imaging's total-body PET scanner shows promise in four new studies Faster scans, lower dose and 'a level of detail never seen in PET'

NorthStar buys IBA electron accelerators for Mo-99 production Will increase production capacity and efficiencies

RadioMedix and Vect-Horus to develop brain theranostic agent for brain cancer Provide diagnosis and treatment of Glioblastoma Multiforme (GBM)

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

DOE to cut Moly-99 deals with four US firms Could be as much as $15 million per company, with partners matching awarded amounts

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

NorthStar, Shine in line for federal funding

por Thomas Dworetzky , Contributing Reporter
Domestic molybdenum-99 (Mo-99) production may benefit from the Federal 2019 Energy & Water Development Appropriations Bill – to the tune of $20 million.

Wisconsin-based NorthStar Medical Radioisotopes and SHINE Medical Technologies – one in Beloit and the other slated to locate in Janesville – may see the support coming from an amendment that was part of the recently signed and approved federal funding for new technology.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



“Medical isotopes are critical to American health care, and our Wisconsin entrepreneurs are working to deploy a Made in America source of this much-needed diagnostic tool for patients and families,” said Wisconsin Senator Tammy Baldwin, who drove the effort along with Ohio Senator Rob Portman to finalize the amendment backing the funding. “This appropriations legislation gets our domestic production back on track to ensure health care providers can source this critical medical isotope domestically and reduce our reliance on foreign sources. I am proud to provide results for our Made in Wisconsin companies that create and innovate to improve public health and save lives.”

Senator Baldwin is a member of the Senate Appropriations Committee.

On October 1, NorthStar was given an Award for Outstanding Achievement by the U.S. Department of Energy’s National Nuclear Security Administration (NNSA) to recognize it as the first U.S.-based Mo-99 for nearly three decades. NorthStar’s RadioGenix System, which produces technetium-99m (Tc-99m) from Mo-99, won FDA approval in February.

At present the U.S. gets 100 percent of its supply from abroad, with the Netherlands being the major source of the material.

“NorthStar’s success directly supports the National Nuclear Security Administration’s goal to reduce the use of highly enriched uranium in civilian commercial applications,” said Peter H. Hanlon, assistant deputy administrator, Office of Material Management and Minimization, NNSA, during the award presentation at the recent NNSA 2018 Annual Topical Meeting, noting that, “NorthStar’s efforts have resulted in a safer world while contributing to a stable supply of this crucial medical radioisotope for American patients.”

The NNSA-NorthStar development process for the RadioGenix System was a seven-year effort. “It’s gratifying that our efforts became realized through the FDA’s approval of the RadioGenix System. NNSA’s close collaboration, outstanding working relationship and support of NorthStar have been instrumental in achieving this success,” said George Messina, Chairman Emeritus of NorthStar Medical Radioisotopes, in a statement.
  Pages: 1 - 2 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS